Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is OPKO Health Stock a Buy?


The coronavirus has brought many small healthcare companies into the limelight in 2020 -- from small drugmakers testing experimental therapies to quiet diagnostics businesses suddenly facing demand for hundreds of millions of tests. 

OPKO Health (NASDAQ: OPK) has found itself in investors' spotlight this year, having parlayed its 2015 acquisition of BioReference Labs into a leading position managing coronavirus testing for sports leagues. But interested investors should consider two key questions: What is OPKO beyond its testing programs, and could the company offer good returns in the future?

Image source: Getty Images

Continue reading


Source Fool.com

Like: 0
OPK
Teilen

Kommentare